Repros Therapeutics Inc (RPRX): I don't think anyone is buying AIS due t...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Repros Therapeutics Inc (RPRX)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	17
Posts	1580
Boards Moderated	0
Alias Born	02/07/2007

Re: DewDiligence post# 339

Tuesday, 05/15/2007 1:40:43 PM

Tuesday, May 15, 2007 1:40:43 PM

I don't think anyone is buying AIS due to LibiGel. They have enough catalysts without the FSD approval. If TEVA brings three products to market using their injection system or they can develop Anturol to market then AIS is extremely undervalued. LibiGel would just be icing on the cake.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent RPRX News

Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024 • GlobeNewswire Inc. • 10/16/2024 08:15:00 PM
Royalty Pharma Declares Fourth Quarter 2024 Dividend • GlobeNewswire Inc. • 10/11/2024 12:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 12:39:00 PM
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement • GlobeNewswire Inc. • 09/03/2024 09:14:32 PM
Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement • GlobeNewswire Inc. • 09/03/2024 09:06:29 PM
Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference • GlobeNewswire Inc. • 08/28/2024 08:15:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 11:20:32 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 11:19:02 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 11:17:16 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 01:02:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:20:53 AM
Royalty Pharma Reports Second Quarter 2024 Results • GlobeNewswire Inc. • 08/08/2024 11:00:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 11:04:01 AM
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 07/29/2024 08:30:11 PM
Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital • GlobeNewswire Inc. • 07/24/2024 12:30:00 PM
Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024 • GlobeNewswire Inc. • 07/19/2024 12:15:00 PM
Royalty Pharma Declares Third Quarter 2024 Dividend • GlobeNewswire Inc. • 07/17/2024 08:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 12:03:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:58:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 09:06:32 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/04/2024 09:12:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 08:57:02 PM
Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/04/2024 08:15:00 PM
Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes • GlobeNewswire Inc. • 06/03/2024 09:15:27 PM
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 06/03/2024 08:59:57 PM

More RPRX News

InvestorsHub NewsWire

FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM

Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM

Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM

Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM

Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow